Delivery Order SPE2DX22D0010-SPE2D824FLK86
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $4,385.80 Firm Fixed Price delivery order contract is for the supply of 12mg hydromorphone hydrochloride extended-release tablets. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,143.85, is for the delivery of 100 tablets of 8 mg hydromorphone hydrochloride extended-release. It is a firm fixed-price delivery order contract with an ultimate completion date of January 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- This federal contract award, with ID SPE2DX22D0010|SPE2D823FCD32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The $4,207.56 firm fixed-price delivery order is for the supply of 16mg hydromorphone hydrochloride extended-release tablets. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $8,603.00 Firm Fixed Price Delivery Order is for the supply of hydromorphone hydrochloride extended-release 16 mg tablets. The award appears to be under a larger Indefinite Delivery Contract (IDC) vehicle that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of hydromorphone hydrochloride extended-release tablets, 32 mg, a pain management medication. The contract is a Firm Fixed Price Delivery Order, with a ceiling value of $2,692.00 and a period of performance through November 18, 2024. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,194.44 firm fixed-price delivery order is for the supply of 4,568,142,759 units of 8 mg hydromorphone tablets. The contract has an ultimate completion date of May 6, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
- This federal contract award, with an ID of SPE2DX22D0010|SPE2D825FCT83, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,477.53, is for the delivery of 12mg hydromorphone hydrochloride extended-release tablets. This is a firm-fixed-price delivery order contract with a period of performance through January 17, 2025. The contract does not have a...
- This federal contract award, with the ID SPE2DB22D1017|SPE2DB24FF5FD, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $2,520.67, is a firm fixed price delivery order for the supply of 4,564,146,984 hydromorphone hydrochloride extended-release 16 mg tablets, with a performance period through April 3, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,415.66 Firm Fixed Price delivery order is for the pharmaceutical product hydromorphone hydrochloride extended-release 8 mg tablets, with an ultimate completion date of December 7, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $1,741.00, is for the delivery of hydromorphone 1 mg/ml in carpules. This is a firm fixed price delivery order contract with a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FLK86Delivery Order
This federal contract award, valued at $4,694.48, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is a firm fixed price delivery order for 12mg hydromorphone hydrochloride extended-release tablets. It has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp is the prime contractor and serves as a major supplier of pharmaceuticals and medical supplies to U.S. government agencies, primarily the Department of Defense. This award is part of a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC enables AmerisourceBergen to provide a comprehensive range of medications and healthcare materials to military treatment programs and facilities worldwide. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 4/4/24 |